Orbis Medicines ApS: Financial statements 2024
CVR: 42715646
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
Orbis Medicines ApS (CVR 42715646) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK -51,629,104 and a net result of DKK -37,020,933 compared with DKK -17,637,755 the year before. Equity in the 2024 report amounted to DKK 127,019,673. The solvency ratio was 80.1%. The company had 1 employee in the financial year.
- Gross Profit
- DKK -51,629,104
- Profit/Loss
- DKK -37,020,933
- Equity
- DKK 127,019,673
- Total Assets
- DKK 158,639,386
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | -51.6 mio. | -37 mio. | 127 mio. | 1 |
| 2023 | - | -25.6 mio. | -17.6 mio. | 68.9 mio. | 0 |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
As of December 27, 2024, Søren Møller has joined the board of directors of Orbis Medicines ApS.
As of December 27, 2024, Morten Døssing has joined the board of directors of Orbis Medicines ApS.
As of December 27, 2024, Marco Boorsma has joined the board of directors of Orbis Medicines ApS.
As of December 27, 2024, Edward Timothy Mathers has joined the board of directors of Orbis Medicines ApS.
As of December 27, 2024, João Carlos Ribas de Almeida has left the board of directors of Orbis Medicines ApS.
As of December 27, 2024, Christian Heinis has left the board of directors of Orbis Medicines ApS.
As of December 27, 2024, Vanessa Carle has left the board of directors of Orbis Medicines ApS.
As of December 27, 2024, Novo Holdings A/S is registered as an owner of Orbis Medicines ApS with an ownership share of 33%.
As of December 27, 2024, is registered as an owner of Orbis Medicines ApS with an ownership share of 10%.
As of December 26, 2024, Morten Døssing has left the board of directors of Orbis Medicines ApS.
About Orbis Medicines ApS
Orbis Medicines ApS is a Danish company of the type Anpartsselskab based in Frederiksberg, founded in 2021. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Morten Døssing. The board consists of Goran Mikael Dolsten (chair), Alonso Ricardo Rodriguez, Edward Timothy Mathers and Marco Boorsma. The company is owned by Novo Holdings A/S, Forbion Ventures Fund VI Coöperatief U.A. and GF 2022 Global VC S.á r.l.. The company has 32 employees (2026). In 2025, the company reported a gross profit of DKK -114,117,791 and a net result of DKK -136,526,045 compared with DKK -37,020,933 the year before. Equity in the 2025 report amounted to DKK 287,462,567.